| TRADING CENTER |
| GTx Announces Reduction in Force - Business Wire | |
Genentech gets FDA bounce - CNNMoney.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.42 | 0.07 / 0.12% | 10.98 |
| GILD | Gilead Sciences Inc | 43.00 | -0.01 / -0.02% | 16.60 |
| CELG | Celgene Corporation | 56.38 | -0.42 / -0.74% | 67.93 |
| 2008 Revenue: | $13.5 M | Headquarters: Memphis, TN |
| Employees: | 147 | CEO: Dr. Mitchell S. Steiner, M.D., F.A.C.S. |
| Net Income: | $-51,780,000.0 | Industry: Biotechnology |
| Market Cap: | $130.8 M | Website: www.gtxinc.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| GTXI | 3.62 | +0.03 / +0.84% | 3.59 | 3.65 | 3.57 | Profile Chart News |